ZyVersa Therapeutics (ZVSA) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts ZVSA Hot Sheet
Join SI Premium – FREE
ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q2 EPS of ($3.31), $0.44 better than the analyst estimate of ($3.75).
For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Morgan Stanley Starts eMemory Technology Inc (3529:TT) at Overweight
- RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
